Masimo Corporation · NASDAQ:MASI

Masimo — Investor Day (December 2025)

22 slides from Masimo's investor day presentation, Dec 3, 2025

  1. Slide 1: Outcomes Research Consortium

    OUTCOMES RESEARCH Consortium Providing the evidence for evidence-based medicine©

  2. Slide 2: Perioperative Mortality

    Perioperative Mortality Daniel I. Sessler, M.D. Vice President for Clinical and Outcomes Research Professor of Anesthesiology UTHealth, Houston www.OR.org DS@OR.org

  3. Slide 3: Dylan Thomas, 1954 quote

    Dylan Thomas, 1954 Time held me green and dying, But I sang in my chains like the sea.

  4. Slide 4: Do not go gentle into that good night

    Dylan Thomas, shortly before dying Do not go gentle into that good night, Old age should burn and rave at close of day; Rage, rage against the dying of the light.

  5. Slide 5: 30-day Postoperative Mortality

    30-day Postoperative Mortality Nepogodiev, Lancet 2019

  6. Slide 6: Causes of Perioperative Mortality

    Causes of Perioperative Mortality Attributable risk • Bleeding 17% • Myocardial injury 16% • Sepsis 12% Respiratory events • ≈45,000 US pts/yr need emergency ventilation – 40% lethal • 40% of ward cardiopulmonary arrests are respiratory – 80% lethal • Largely preventable VISION Investigators CMAJ 20

  7. Slide 7: Continuous Ward MAP Monitoring (n=312)

    Continuous Ward MAP Monitoring (n=312) Routine vital signs missed half the patients with MAP <65 mmHg for 15 minutes Turan, Anesthesiology 2019

  8. Slide 8: Respiratory Complications

    Respiratory Complications Respiratory arrests should not kill hospitalized patients Causes •Obstruction •Respiratory muscle weakness, including residual blocks •Reduced ventilation, often from pain •Impaired respiratory control And…

  9. Slide 9: Opioids & Sedatives and Cardiac Arrest

    Opioids & Sedatives Cardiac Arrest No Cardiac Arrest (n=96,554) (n=12,180,137) OR 95%CI Opioids & Sedatives 41% 22% 3.47 (3.40, 3.54) Opioids only 28% 31% 1.81 (1.77, 1.85) Sedatives only 14% 14% 1.82 (1.78, 1.87) Neither opioids nor 17% 33% Ref sedatives Overdyk, PLoS One, 2018

  10. Slide 10: Blinded Saturation Over Time

    Blinded Saturation Over Time Nurses missed 90% of patients who had 1 continuous hour of saturation <90% More than 10% of ward saturations were <90% Sun, A&A 2015

  11. Slide 11: Opioid-induced Respiratory Depression

    Opioid-induced Respiratory Depression Closed-claims analysis •77% of episodes = death or severe brain injury •88% within 24 hours of anesthesia 97% deemed preventable •42% within 2 hours of last nursing check Potential causes •Multiple prescribers •Potentiating non-opioid sedatives Lee et al, Anesth

  12. Slide 12: Vital Sign Monitoring

    Vital Sign Monitoring We monitor vital signs about the way we did a half-century ago We’re still stuck on “failure to rescue” rather than preventing complications Continuous ward vital sign monitoring may help

  13. Slide 13: Arrests Preceded by Abnormalities

    Arrests Proceeded by Abnormalities 100 90% 95 85% 90 80% 75% Most in-hospital 85 70% cardiorespiratory 80 arrests preceded by Mortality, % 75 70 hours of vital sign 65 abnormalities 60 55 50 0 1 2 3 0 1 2 3 Abnormal Severely Abnormal Number of Pre-Arrest Abnormal Vital Signs Anderson, Resuscitation

  14. Slide 14: Dartmouth 10-year Outcomes Study

    Dartmouth 10-year Outcomes Study Continuous Masimo surveillance monitoring of general ward patients (n=111,488) No OIRD deaths among continuously monitored patients One OIRD-related death among patient for whom continuous monitoring was available but not used Continuous SpO2 monitoring reduced death

  15. Slide 15: Continuous Ward Monitoring Helps

    Continuous Ward Monitoring Helps ‘Before and After” 8-month comparative outcomes study Continuous SpO2 monitoring using Masimo SET with Patient SafetyNet King Saud Medical City - 1,200 bed hospital Before Patient After Patient P value SafetyNet SafetyNet ↓ Mortality CPR Event Rate 3.3% 1.95% 0.01 ↓

  16. Slide 16: Impact to Cost of Care

    Impact to Cost of Care Dartmouth clinical outcome study using Masimo SET with Patient SafetyNet Cost-of-care analysis of 31,993 ward patients admitted July 2016 – Dec 2019 Operating margin savings of $5,500 per patient rescue prevented and $10,700 per patient for rescue/care transfer prevented Signi

  17. Slide 17: CONSTANT Trial: Methods

    CONSTANT Trial: Methods 500 Patients recovering from major noncardiac surgery Intermittent postop nursing vital signs per routine Continuous vital sign monitoring for 48 hours •Radius PPG and Patient SafetyNet Randomization •Blinded continuous vital sign monitoring •Unblinded continuous vital sign m

  18. Slide 18: CONSTANT Trial: Primary Hypothesis

    CONSTANT Trial: Primary Hypothesis Unblinded continuous ward monitoring reduces a composite of areas exceeding the thresholds of desaturation (<85%), bradypnea (<5 breaths/min), tachypnea (>25 breaths/min), tachycardia (heart rate >130 beats/min), bradycardia (heart rate <35 beats/min), mean arteria

  19. Slide 19: CONSTANT Trial: Secondary Hypothesis

    CONSTANT Trial: Secondary Hypothesis Unblinded continuous ward monitoring increases a composite of clinical interventions for desaturation, hypoventilation, tachypnea, tachycardia, bradycardia, and hypotension within 48 hours after major non-cardiac surgery.

  20. Slide 20: Summary: Postop Mortality is Preventable

    Summary: Postop Mortality is Preventable Postoperative deaths are world’s 3rd leading cause of death Major causes are cardiovascular and respiratory events •Preceded by vital sign abnormalities •Most are missed with conventional 4-hour vital sign monitoring Continuous ward monitoring is likely to: •

  21. Slide 21: Carpe Diem

    Carpe Diem

  22. Slide 22: And that's all folks…

    And that’s all folks… Selected OUTCOMES RESEARCH covers since 2023

Masimo — Investor Day (December 2025) on 6ix